178 related articles for article (PubMed ID: 1374450)
21. The allorecognition of H-2Kb-specific CD4-CD8- T cell hybridomas is influenced by the substitution at residue 256 of MHC class I molecules.
Tanabe M; Minami M; Kano K; Takiguchi M
J Immunol; 1990 Sep; 145(6):1968-73. PubMed ID: 2118159
[TBL] [Abstract][Full Text] [Related]
22. Tissue distribution of human minor histocompatibility antigens. Ubiquitous versus restricted tissue distribution indicates heterogeneity among human cytotoxic T lymphocyte-defined non-MHC antigens.
de Bueger M; Bakker A; Van Rood JJ; Van der Woude F; Goulmy E
J Immunol; 1992 Sep; 149(5):1788-94. PubMed ID: 1380540
[TBL] [Abstract][Full Text] [Related]
23. The alpha 1/alpha 2 domains of class I HLA molecules confer resistance to natural killing.
Storkus WJ; Alexander J; Payne JA; Cresswell P; Dawson JR
J Immunol; 1989 Dec; 143(11):3853-7. PubMed ID: 2479694
[TBL] [Abstract][Full Text] [Related]
24. Analysis of hybrid H-2D and L antigens with reciprocally mismatched aminoterminal domains: functional T cell recognition requires preservation of fine structural determinants.
McCluskey J; Boyd L; Foo M; Forman J; Margulies DH; Bluestone JA
J Immunol; 1986 Dec; 137(12):3881-90. PubMed ID: 2431046
[TBL] [Abstract][Full Text] [Related]
25. Measles virus-specific human T cell clones. Characterization of specificity and function of CD4+ helper/cytotoxic and CD8+ cytotoxic T cell clones.
van Binnendijk RS; Poelen MC; de Vries P; Voorma HO; Osterhaus AD; Uytdehaag FG
J Immunol; 1989 Apr; 142(8):2847-54. PubMed ID: 2467943
[TBL] [Abstract][Full Text] [Related]
26. Activation of human T cell clones and Jurkat cells by cross-linking class I MHC molecules.
Geppert TD; Wacholtz MC; Patel SS; Lightfoot E; Lipsky PE
J Immunol; 1989 Jun; 142(11):3763-72. PubMed ID: 2469725
[TBL] [Abstract][Full Text] [Related]
27. Interactions between the amino-terminal domains of MHC class II molecules have a profound effect on serologic and T cell recognition: an analysis using recombinant HLA-DR/H-2E molecules.
Barber LD; Lechler RI
J Immunol; 1991 Oct; 147(7):2346-53. PubMed ID: 1717556
[TBL] [Abstract][Full Text] [Related]
28. A rat anti-mouse T4 monoclonal antibody (H129.19) inhibits the proliferation of Ia-reactive T cell clones and delineates two phenotypically distinct (T4+, Lyt-2,3-, and T4-, Lyt-2,3+) subsets among anti-Ia cytolytic T cell clones.
Pierres A; Naquet P; Van Agthoven A; Bekkhoucha F; Denizot F; Mishal Z; Schmitt-Verhulst AM; Pierres M
J Immunol; 1984 Jun; 132(6):2775-82. PubMed ID: 6202760
[TBL] [Abstract][Full Text] [Related]
29. Alloantigen-specific cytotoxic clones bearing the alpha,beta T cell antigen receptor but not CD4 or CD8 molecules.
Rivas A; Koide J; Laus R; Engleman EG
J Immunol; 1990 Jul; 145(2):470-6. PubMed ID: 2142178
[TBL] [Abstract][Full Text] [Related]
30. Selective loss of human leukocyte class I allospecificities and staining of melanoma cells by monoclonal antibodies recognizing monomorphic determinants of class I human leukocyte antigens.
Kageshita T; Wang Z; Calorini L; Yoshii A; Kimura T; Ono T; Gattoni-Celli S; Ferrone S
Cancer Res; 1993 Jul; 53(14):3349-54. PubMed ID: 7686817
[TBL] [Abstract][Full Text] [Related]
31. Tumor allograft rejection is mainly mediated by CD8+ cytotoxic T lymphocytes stimulated with class I alloantigens in cooperation with CD4+ helper T cells recognizing class II alloantigens.
Tomita Y; Mayumi H; Eto M; Nomoto K
J Immunol; 1990 Mar; 144(6):2425-35. PubMed ID: 1968930
[TBL] [Abstract][Full Text] [Related]
32. The cytoplasmic and the transmembrane domains are not sufficient for class I MHC signal transduction.
Gur H; Geppert TD; Wacholtz MC; Lipsky PE
Cell Immunol; 1999 Feb; 191(2):105-16. PubMed ID: 9973532
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of T cell activation by a monoclonal antibody reactive against the alpha 3 domain of human MHC class I molecules.
Smith DM; Bluestone JA; Jeyarajah DR; Newberg MH; Engelhard VH; Thistlethwaite JR; Woodle ES
J Immunol; 1994 Aug; 153(3):1054-67. PubMed ID: 7913109
[TBL] [Abstract][Full Text] [Related]
34. Diversity in the fine specificity and idiotypic profile of mouse anti-HLA-DR monoclonal antibody elicited with the syngeneic anti-idiotypic monoclonal antibody F5-830.
Mariani SM; Armandola EA; Ferrone S
J Immunol; 1991 Aug; 147(4):1322-30. PubMed ID: 1714480
[TBL] [Abstract][Full Text] [Related]
35. The role of HLA class I antigens in recognition of melanoma cells by tumor-specific cytotoxic T lymphocytes. Evidence for shared tumor antigens.
Darrow TL; Slingluff CL; Seigler HF
J Immunol; 1989 May; 142(9):3329-35. PubMed ID: 2785141
[TBL] [Abstract][Full Text] [Related]
36. Cross-linking of HLA class II antigens modulates the release of tumor necrosis factor-alpha by the EBV-B lymphoblastoid cell line JY.
Altomonte M; Pucillo C; Damante G; Maio M
J Immunol; 1993 Nov; 151(10):5115-22. PubMed ID: 8228213
[TBL] [Abstract][Full Text] [Related]
37. Evidence for the expression of non-HLA-A,-B,-C class I genes in the human fetal liver.
Houlihan JM; Biro PA; Fergar-Payne A; Simpson KL; Holmes CH
J Immunol; 1992 Jul; 149(2):668-75. PubMed ID: 1624808
[TBL] [Abstract][Full Text] [Related]
38. Distinct HLA-DR epitopes and distinct families of HLA-Dr molecules defined by 15 monoclonal antibodies (mAb) either anti-DR or allo-anti-Iak cross-reacting with human DR molecule. I. Cross-inhibition studies of mAb cell surface fixation and differential binding of mAb to detergent-solubilized HLA molecules immobilized to a solid phase by a first mAb.
Rebai N; Malissen B; Pierres M; Accolla RS; Corte G; Mawas C
Eur J Immunol; 1983 Feb; 13(2):106-11. PubMed ID: 6187579
[TBL] [Abstract][Full Text] [Related]
39. Role of dendritic cells in the regulation of class I restricted cytotoxic T lymphocyte responses.
Boog CJ; Boes J; Melief CJ
J Immunol; 1988 May; 140(10):3331-7. PubMed ID: 2452183
[TBL] [Abstract][Full Text] [Related]
40. The functional significance of two amino acid polymorphisms in the antigen-presenting domain of class I MHC molecules. Molecular dissection of Kbm3.
Pullen JK; Hunt HD; Horton RM; Pease LR
J Immunol; 1989 Sep; 143(5):1674-9. PubMed ID: 2788191
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
